Ranked [title] Word (excluding stopwords, and 2-character and smaller words) list
Total: 481, Word count: 1059, All words count: 1584
View: Overview. Sorted by number of publications (Pubs).
| # | Word | Pubs | Percent | TLCS | TGCS |
|---|---|---|---|---|---|
| 1 | EMBRYOS | 28 | 18.9 | 51 | 1007 |
| 2 | SHEEP | 23 | 15.5 | 111 | 2267 |
| 3 | TRANSFER | 21 | 14.2 | 60 | 1216 |
| 4 | NUCLEAR | 19 | 12.8 | 61 | 1110 |
| 5 | DEVELOPMENT | 16 | 10.8 | 43 | 715 |
| 6 | EMBRYO | 15 | 10.1 | 22 | 431 |
| 7 | CELL | 14 | 9.5 | 34 | 703 |
| 8 | CLONED | 14 | 9.5 | 34 | 803 |
| 9 | CLONING | 14 | 9.5 | 3 | 67 |
| 10 | EFFECT | 14 | 9.5 | 24 | 391 |
| 11 | SURVIVAL | 12 | 8.1 | 18 | 428 |
| 12 | MOUSE | 10 | 6.8 | 16 | 349 |
| 13 | BOAR | 9 | 6.1 | 18 | 193 |
| 14 | CELLS | 9 | 6.1 | 31 | 1265 |
| 15 | HUMAN | 9 | 6.1 | 20 | 636 |
| 16 | GROWTH | 8 | 5.4 | 12 | 212 |
| 17 | PRESERVATION | 8 | 5.4 | 13 | 301 |
| 18 | BOVINE | 7 | 4.7 | 12 | 284 |
| 19 | EMBRYONIC | 7 | 4.7 | 6 | 159 |
| 20 | FETAL | 7 | 4.7 | 55 | 1639 |
| 21 | MICE | 7 | 4.7 | 5 | 56 |
| 22 | PRODUCTION | 7 | 4.7 | 8 | 97 |
| 23 | SEMEN | 7 | 4.7 | 15 | 165 |
| 24 | FOLLOWING | 6 | 4.1 | 12 | 183 |
| 25 | LARGE | 6 | 4.1 | 17 | 298 |
| 26 | LOW-TEMPERATURE | 6 | 4.1 | 12 | 245 |
| 27 | SOMATIC | 6 | 4.1 | 9 | 123 |
| 28 | STAGE | 6 | 4.1 | 14 | 326 |
| 29 | STEM | 6 | 4.1 | 5 | 19 |
| 30 | COW | 5 | 3.4 | 5 | 336 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 31 | CULTURE | 5 | 3.4 | 12 | 270 |
| 32 | EFFECTS | 5 | 3.4 | 4 | 47 |
| 33 | FROZEN | 5 | 3.4 | 11 | 130 |
| 34 | METHODS | 5 | 3.4 | 3 | 55 |
| 35 | OOCYTES | 5 | 3.4 | 6 | 75 |
| 36 | OVINE | 5 | 3.4 | 9 | 101 |
| 37 | SPERMATOZOA | 5 | 3.4 | 8 | 76 |
| 38 | VITRO | 5 | 3.4 | 5 | 114 |
| 39 | ANIMAL | 4 | 2.7 | 1 | 32 |
| 40 | BREEDING | 4 | 2.7 | 1 | 32 |
| 41 | CONTROL | 4 | 2.7 | 7 | 87 |
| 42 | DNA | 4 | 2.7 | 3 | 117 |
| 43 | EARLY | 4 | 2.7 | 1 | 63 |
| 44 | FREEZING | 4 | 2.7 | 7 | 189 |
| 45 | INFLUENCE | 4 | 2.7 | 22 | 265 |
| 46 | MAMMALIAN | 4 | 2.7 | 33 | 1190 |
| 47 | MANIPULATION | 4 | 2.7 | 2 | 82 |
| 48 | MEISHAN | 4 | 2.7 | 6 | 135 |
| 49 | METHOD | 4 | 2.7 | 4 | 37 |
| 50 | MILK | 4 | 2.7 | 10 | 355 |
| 51 | NEW | 4 | 2.7 | 2 | 16 |
| 52 | OFFSPRING | 4 | 2.7 | 43 | 1328 |
| 53 | PIG | 4 | 2.7 | 3 | 105 |
| 54 | PROGRESS | 4 | 2.7 | 1 | 39 |
| 55 | RATE | 4 | 2.7 | 8 | 245 |
| 56 | SPERM | 4 | 2.7 | 3 | 168 |
| 57 | TRANSGENIC | 4 | 2.7 | 24 | 702 |
| 58 | VIABLE | 4 | 2.7 | 32 | 1247 |
| 59 | ACTIVATED | 3 | 2.0 | 5 | 72 |
| 60 | ACTIVATION | 3 | 2.0 | 5 | 41 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 61 | ASSOCIATED | 3 | 2.0 | 9 | 241 |
| 62 | CATTLE-BREEDING | 3 | 2.0 | 3 | 45 |
| 63 | CELL-CYCLE | 3 | 2.0 | 15 | 205 |
| 64 | CONCEPTUS | 3 | 2.0 | 8 | 104 |
| 65 | DERIVED | 3 | 2.0 | 32 | 1144 |
| 66 | DOLLY | 3 | 2.0 | 3 | 31 |
| 67 | EXPRESSION | 3 | 2.0 | 9 | 327 |
| 68 | FORMATION | 3 | 2.0 | 3 | 91 |
| 69 | GENE | 3 | 2.0 | 6 | 79 |
| 70 | GENE-TRANSFER | 3 | 2.0 | 10 | 103 |
| 71 | GENETIC | 3 | 2.0 | 2 | 42 |
| 72 | HEIFERS | 3 | 2.0 | 2 | 106 |
| 73 | IMPLICATIONS | 3 | 2.0 | 8 | 124 |
| 74 | INBRED | 3 | 2.0 | 4 | 10 |
| 75 | LAMB | 3 | 2.0 | 1 | 5 |
| 76 | LIFE | 3 | 2.0 | 0 | 27 |
| 77 | LINE | 3 | 2.0 | 23 | 504 |
| 78 | LOW | 3 | 2.0 | 1 | 70 |
| 79 | MAMMALS | 3 | 2.0 | 2 | 154 |
| 80 | MEDICINE | 3 | 2.0 | 1 | 15 |
| 81 | MILK-COMPOSITION | 3 | 2.0 | 0 | 15 |
| 82 | OVULATION | 3 | 2.0 | 2 | 38 |
| 83 | PIGS | 3 | 2.0 | 1 | 21 |
| 84 | POTENTIAL | 3 | 2.0 | 2 | 13 |
| 85 | PREGNANCY | 3 | 2.0 | 4 | 50 |
| 86 | PRESENCE | 3 | 2.0 | 4 | 73 |
| 87 | RESPONSE | 3 | 2.0 | 1 | 73 |
| 88 | ROLE | 3 | 2.0 | 1 | 5 |
| 89 | TECHNIQUES | 3 | 2.0 | 0 | 0 |
| 90 | THAWED | 3 | 2.0 | 5 | 44 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 91 | TRANSPORT | 3 | 2.0 | 3 | 166 |
| 92 | USE | 3 | 2.0 | 0 | 49 |
| 93 | USING | 3 | 2.0 | 4 | 10 |
| 94 | UTERINE | 3 | 2.0 | 2 | 31 |
| 95 | VARIATION | 3 | 2.0 | 6 | 92 |
| 96 | WHITE | 3 | 2.0 | 5 | 100 |
| 97 | ADULT | 2 | 1.4 | 31 | 1135 |
| 98 | AGENTS | 2 | 1.4 | 4 | 42 |
| 99 | ANALYSIS | 2 | 1.4 | 7 | 146 |
| 100 | APPLICATION | 2 | 1.4 | 0 | 37 |
| 101 | APPLICATIONS | 2 | 1.4 | 0 | 21 |
| 102 | BEGINNING | 2 | 1.4 | 0 | 56 |
| 103 | BIOLOGY | 2 | 1.4 | 1 | 40 |
| 104 | BIOTECHNOLOGY | 2 | 1.4 | 0 | 10 |
| 105 | BREED | 2 | 1.4 | 1 | 5 |
| 106 | CAPACITY | 2 | 1.4 | 7 | 85 |
| 107 | CLEAVAGE | 2 | 1.4 | 4 | 22 |
| 108 | CLONE | 2 | 1.4 | 1 | 40 |
| 109 | COMPOSITION | 2 | 1.4 | 2 | 24 |
| 110 | CONCENTRATION | 2 | 1.4 | 2 | 67 |
| 111 | CONFLUENCE | 2 | 1.4 | 4 | 10 |
| 112 | COOLING | 2 | 1.4 | 3 | 178 |
| 113 | COPPER | 2 | 1.4 | 1 | 5 |
| 114 | CULTURED | 2 | 1.4 | 19 | 513 |
| 115 | DAM | 2 | 1.4 | 1 | 5 |
| 116 | DAY | 2 | 1.4 | 2 | 29 |
| 117 | DEEP | 2 | 1.4 | 3 | 32 |
| 118 | DETERMINING | 2 | 1.4 | 1 | 5 |
| 119 | DEVELOPMENTAL | 2 | 1.4 | 1 | 40 |
| 120 | DIETARY | 2 | 1.4 | 1 | 5 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 121 | DILUENT | 2 | 1.4 | 3 | 30 |
| 122 | ELECTRICAL | 2 | 1.4 | 2 | 7 |
| 123 | ENVIRONMENT | 2 | 1.4 | 15 | 98 |
| 124 | ESTABLISHMENT | 2 | 1.4 | 1 | 16 |
| 125 | EWE | 2 | 1.4 | 1 | 57 |
| 126 | FACTOR | 2 | 1.4 | 12 | 338 |
| 127 | FACTORS | 2 | 1.4 | 1 | 118 |
| 128 | FERTILIZING-CAPACITY | 2 | 1.4 | 4 | 41 |
| 129 | FIBROBLASTS | 2 | 1.4 | 12 | 314 |
| 130 | FSH | 2 | 1.4 | 0 | 29 |
| 131 | FUNCTIONAL | 2 | 1.4 | 2 | 45 |
| 132 | GENE-EXPRESSION | 2 | 1.4 | 0 | 56 |
| 133 | GILTS | 2 | 1.4 | 5 | 78 |
| 134 | GLYCEROL | 2 | 1.4 | 3 | 35 |
| 135 | HALOTHANE | 2 | 1.4 | 0 | 18 |
| 136 | HIGH | 2 | 1.4 | 0 | 18 |
| 137 | IGF2R | 2 | 1.4 | 8 | 131 |
| 138 | IMPACT | 2 | 1.4 | 2 | 15 |
| 139 | IMPROVED | 2 | 1.4 | 7 | 97 |
| 140 | IMPROVEMENT | 2 | 1.4 | 2 | 7 |
| 141 | INDUCED | 2 | 1.4 | 1 | 31 |
| 142 | INTRODUCTION | 2 | 1.4 | 0 | 0 |
| 143 | LANDRACE | 2 | 1.4 | 3 | 62 |
| 144 | LESSONS | 2 | 1.4 | 1 | 44 |
| 145 | LIVESTOCK | 2 | 1.4 | 6 | 84 |
| 146 | MATED | 2 | 1.4 | 3 | 57 |
| 147 | MATERNAL | 2 | 1.4 | 5 | 176 |
| 148 | METHYLATION | 2 | 1.4 | 0 | 10 |
| 149 | MOLECULAR | 2 | 1.4 | 0 | 9 |
| 150 | MORPHOLOGY | 2 | 1.4 | 3 | 28 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 151 | MOTILITY | 2 | 1.4 | 3 | 28 |
| 152 | NORMAL | 2 | 1.4 | 1 | 17 |
| 153 | NUCLEI | 2 | 1.4 | 12 | 341 |
| 154 | OOCYTE | 2 | 1.4 | 0 | 28 |
| 155 | OPPORTUNITIES | 2 | 1.4 | 0 | 9 |
| 156 | OVERGROWTH | 2 | 1.4 | 7 | 159 |
| 157 | OVIDUCT | 2 | 1.4 | 0 | 109 |
| 158 | OVIDUCTS | 2 | 1.4 | 3 | 57 |
| 159 | OVULATED | 2 | 1.4 | 0 | 0 |
| 160 | PHARMACEUTICAL | 2 | 1.4 | 2 | 40 |
| 161 | PORCINE | 2 | 1.4 | 2 | 7 |
| 162 | PREANTRAL | 2 | 1.4 | 0 | 38 |
| 163 | PREIMPLANTATION | 2 | 1.4 | 0 | 20 |
| 164 | PROGESTERONE | 2 | 1.4 | 2 | 68 |
| 165 | PROTECTIVE | 2 | 1.4 | 4 | 42 |
| 166 | PROTEIN | 2 | 1.4 | 7 | 90 |
| 167 | PROTEINS | 2 | 1.4 | 2 | 40 |
| 168 | RECOMBINANT | 2 | 1.4 | 1 | 72 |
| 169 | RECONSTITUTED | 2 | 1.4 | 4 | 22 |
| 170 | RECONSTRUCTED | 2 | 1.4 | 12 | 183 |
| 171 | REGIME | 2 | 1.4 | 1 | 5 |
| 172 | REPRODUCTION | 2 | 1.4 | 0 | 18 |
| 173 | REPRODUCTIVE | 2 | 1.4 | 0 | 2 |
| 174 | REPRODUCTIVE-PERFORMANCE | 2 | 1.4 | 0 | 22 |
| 175 | RESEARCH | 2 | 1.4 | 0 | 2 |
| 176 | SOMATOTROPIN | 2 | 1.4 | 1 | 72 |
| 177 | STATUS | 2 | 1.4 | 1 | 5 |
| 178 | STORED | 2 | 1.4 | 2 | 28 |
| 179 | SUPEROVULATORY | 2 | 1.4 | 1 | 72 |
| 180 | SYNDROME | 2 | 1.4 | 12 | 193 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 181 | TEMPORARY | 2 | 1.4 | 2 | 7 |
| 182 | THAWING | 2 | 1.4 | 5 | 176 |
| 183 | THERAPY | 2 | 1.4 | 0 | 2 |
| 184 | TIME | 2 | 1.4 | 1 | 10 |
| 185 | TRANSPLANTATION | 2 | 1.4 | 18 | 192 |
| 186 | WARMING | 2 | 1.4 | 3 | 158 |
| 187 | ABERRANT | 1 | 0.7 | 2 | 50 |
| 188 | ACTIVE | 1 | 0.7 | 3 | 181 |
| 189 | ACTIVITY | 1 | 0.7 | 11 | 138 |
| 190 | ADVANCED | 1 | 0.7 | 2 | 7 |
| 191 | ADVANCES | 1 | 0.7 | 2 | 7 |
| 192 | AFFECTING | 1 | 0.7 | 0 | 14 |
| 193 | AGAIN | 1 | 0.7 | 0 | 0 |
| 194 | AGENT | 1 | 0.7 | 3 | 154 |
| 195 | ALLOCATION | 1 | 0.7 | 0 | 6 |
| 196 | ALPHA | 1 | 0.7 | 6 | 78 |
| 197 | ALPHA-1-ANTITRYPSIN | 1 | 0.7 | 3 | 181 |
| 198 | ALTERED | 1 | 0.7 | 1 | 12 |
| 199 | ANIMALS | 1 | 0.7 | 0 | 2 |
| 200 | ANTI-HEMOPHILIC | 1 | 0.7 | 5 | 134 |
| 201 | ANTRAL | 1 | 0.7 | 0 | 3 |
| 202 | ANTRUM | 1 | 0.7 | 0 | 35 |
| 203 | ARRANGEMENT | 1 | 0.7 | 0 | 16 |
| 204 | ASK | 1 | 0.7 | 0 | 1 |
| 205 | ASSOCIATION | 1 | 0.7 | 1 | 57 |
| 206 | ASYNCHRONOUS | 1 | 0.7 | 13 | 91 |
| 207 | AVAILABILITY | 1 | 0.7 | 1 | 3 |
| 208 | BASIC | 1 | 0.7 | 0 | 0 |
| 209 | BETA-HYDROXYSTEROID | 1 | 0.7 | 1 | 11 |
| 210 | BINDING | 1 | 0.7 | 1 | 12 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 211 | BLASTOCYST | 1 | 0.7 | 4 | 63 |
| 212 | BLASTOCYSTS | 1 | 0.7 | 0 | 6 |
| 213 | BREEDS | 1 | 0.7 | 0 | 5 |
| 214 | BRITAIN | 1 | 0.7 | 1 | 7 |
| 215 | BRITISH | 1 | 0.7 | 0 | 17 |
| 216 | CATTLE | 1 | 0.7 | 11 | 181 |
| 217 | CHANGE | 1 | 0.7 | 7 | 125 |
| 218 | CHARACTERIZATION | 1 | 0.7 | 0 | 0 |
| 219 | CHILD-DEVELOPMENT | 1 | 0.7 | 0 | 1 |
| 220 | CHIMAERIC | 1 | 0.7 | 0 | 6 |
| 221 | CHINESE | 1 | 0.7 | 3 | 45 |
| 222 | CLAIM | 1 | 0.7 | 0 | 4 |
| 223 | CLONES | 1 | 0.7 | 0 | 1 |
| 224 | COLLECTION | 1 | 0.7 | 0 | 2 |
| 225 | COMBINING | 1 | 0.7 | 0 | 0 |
| 226 | COMPARISON | 1 | 0.7 | 1 | 35 |
| 227 | COMPETENCE | 1 | 0.7 | 0 | 0 |
| 228 | CONCENTRATIONS | 1 | 0.7 | 1 | 11 |
| 229 | CONDITIONS | 1 | 0.7 | 0 | 3 |
| 230 | CONFIRMATION | 1 | 0.7 | 0 | 1 |
| 231 | CONSERVATION | 1 | 0.7 | 1 | 6 |
| 232 | CONSERVED | 1 | 0.7 | 0 | 13 |
| 233 | CONTACT | 1 | 0.7 | 1 | 10 |
| 234 | CONTAINED | 1 | 0.7 | 1 | 8 |
| 235 | CONTRALATERAL | 1 | 0.7 | 0 | 0 |
| 236 | COPING | 1 | 0.7 | 1 | 3 |
| 237 | CORPORA | 1 | 0.7 | 0 | 22 |
| 238 | COULD | 1 | 0.7 | 0 | 0 |
| 239 | COWS | 1 | 0.7 | 2 | 23 |
| 240 | CREATE | 1 | 0.7 | 0 | 0 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 241 | CROSSBRED | 1 | 0.7 | 0 | 22 |
| 242 | CRYOPROTECTIVE | 1 | 0.7 | 3 | 154 |
| 243 | CULTURAL | 1 | 0.7 | 0 | 3 |
| 244 | CUMULUS | 1 | 0.7 | 0 | 28 |
| 245 | CURRENT | 1 | 0.7 | 0 | 2 |
| 246 | CYTOPLASMIC | 1 | 0.7 | 11 | 138 |
| 247 | CYTOPLASTS | 1 | 0.7 | 1 | 9 |
| 248 | DAYS | 1 | 0.7 | 0 | 2 |
| 249 | DEEP-FREEZE | 1 | 0.7 | 1 | 7 |
| 250 | DEFICIENCIES | 1 | 0.7 | 4 | 59 |
| 251 | DEGREES | 1 | 0.7 | 2 | 25 |
| 252 | DEGREES-C | 1 | 0.7 | 0 | 3 |
| 253 | DEGREESC | 1 | 0.7 | 0 | 24 |
| 254 | DEHYDROGENASE | 1 | 0.7 | 1 | 11 |
| 255 | DELETION | 1 | 0.7 | 6 | 78 |
| 256 | DEMETHYLATION | 1 | 0.7 | 0 | 2 |
| 257 | DEOXYRIBONUCLEIC-ACID | 1 | 0.7 | 8 | 120 |
| 258 | DEPEND | 1 | 0.7 | 0 | 28 |
| 259 | DETERMINE | 1 | 0.7 | 0 | 0 |
| 260 | DIFFERENT | 1 | 0.7 | 0 | 5 |
| 261 | DILUTION | 1 | 0.7 | 1 | 10 |
| 262 | DON | 1 | 0.7 | 1 | 40 |
| 263 | DONOR | 1 | 0.7 | 0 | 3 |
| 264 | DYNAMICS | 1 | 0.7 | 0 | 8 |
| 265 | EGG-YOLK | 1 | 0.7 | 1 | 8 |
| 266 | EMBRYONAL | 1 | 0.7 | 2 | 39 |
| 267 | EMBRYONIC-DEVELOPMENT | 1 | 0.7 | 13 | 91 |
| 268 | ENHANCES | 1 | 0.7 | 0 | 26 |
| 269 | ENUCLEATED | 1 | 0.7 | 4 | 63 |
| 270 | ENUCLEATION | 1 | 0.7 | 1 | 9 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 271 | EPIGENETIC | 1 | 0.7 | 7 | 125 |
| 272 | ESSENTIAL | 1 | 0.7 | 2 | 10 |
| 273 | ESTROUS-CYCLE | 1 | 0.7 | 0 | 2 |
| 274 | ESTRUS | 1 | 0.7 | 1 | 34 |
| 275 | ETERNAL | 1 | 0.7 | 0 | 4 |
| 276 | ETHICAL | 1 | 0.7 | 0 | 0 |
| 277 | EUROPEAN | 1 | 0.7 | 1 | 35 |
| 278 | EVALUATION | 1 | 0.7 | 4 | 59 |
| 279 | EVIDENCE | 1 | 0.7 | 1 | 57 |
| 280 | EWES | 1 | 0.7 | 0 | 13 |
| 281 | EXPANSION | 1 | 0.7 | 0 | 28 |
| 282 | EXPERIMENTS | 1 | 0.7 | 3 | 132 |
| 283 | EXPERTS | 1 | 0.7 | 0 | 1 |
| 284 | EXPOSURE | 1 | 0.7 | 2 | 7 |
| 285 | FACTOR-IX | 1 | 0.7 | 5 | 134 |
| 286 | FARM-ANIMALS | 1 | 0.7 | 4 | 72 |
| 287 | FERTILISING | 1 | 0.7 | 1 | 3 |
| 288 | FERTILIZING | 1 | 0.7 | 6 | 82 |
| 289 | FETUSES | 1 | 0.7 | 4 | 59 |
| 290 | FICTION | 1 | 0.7 | 0 | 4 |
| 291 | FINDING | 1 | 0.7 | 0 | 1 |
| 292 | FLEXIBLE | 1 | 0.7 | 0 | 16 |
| 293 | FLUIDS | 1 | 0.7 | 0 | 2 |
| 294 | FOLLICLE | 1 | 0.7 | 0 | 3 |
| 295 | FOLLICLES | 1 | 0.7 | 0 | 35 |
| 296 | FREQUENCY | 1 | 0.7 | 0 | 2 |
| 297 | GALACTOSYL | 1 | 0.7 | 6 | 78 |
| 298 | GENOTYPES | 1 | 0.7 | 0 | 84 |
| 299 | GERMINAL | 1 | 0.7 | 2 | 10 |
| 300 | GESTATION | 1 | 0.7 | 0 | 22 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 301 | GESTATIONAL | 1 | 0.7 | 4 | 59 |
| 302 | GGTA | 1 | 0.7 | 6 | 78 |
| 303 | GONADOTROPIN | 1 | 0.7 | 1 | 46 |
| 304 | GROUPS | 1 | 0.7 | 0 | 5 |
| 305 | HER | 1 | 0.7 | 0 | 1 |
| 306 | HIGH-LEVEL | 1 | 0.7 | 3 | 181 |
| 307 | HOLD | 1 | 0.7 | 0 | 4 |
| 308 | HORMONE | 1 | 0.7 | 4 | 72 |
| 309 | HOURS | 1 | 0.7 | 0 | 3 |
| 310 | HUMANS | 1 | 0.7 | 1 | 40 |
| 311 | IAN | 1 | 0.7 | 0 | 0 |
| 312 | IGF | 1 | 0.7 | 1 | 12 |
| 313 | IGF2-H | 1 | 0.7 | 1 | 6 |
| 314 | IMMUNOHISTOCHEMICAL | 1 | 0.7 | 0 | 0 |
| 315 | IMPERATIVE | 1 | 0.7 | 0 | 0 |
| 316 | IMPORTANCE | 1 | 0.7 | 0 | 4 |
| 317 | IMPRINTING | 1 | 0.7 | 1 | 6 |
| 318 | IN-UTERO | 1 | 0.7 | 0 | 34 |
| 319 | IN-VITRO | 1 | 0.7 | 1 | 2 |
| 320 | INCIDENCE | 1 | 0.7 | 0 | 17 |
| 321 | INEFFICIENT | 1 | 0.7 | 0 | 2 |
| 322 | INFORMATION | 1 | 0.7 | 0 | 1 |
| 323 | INHIBITOR | 1 | 0.7 | 1 | 11 |
| 324 | INSEMINATION | 1 | 0.7 | 6 | 82 |
| 325 | INTEGRATED | 1 | 0.7 | 0 | 12 |
| 326 | INTEGRATION | 1 | 0.7 | 3 | 34 |
| 327 | INTERACTIONS | 1 | 0.7 | 8 | 120 |
| 328 | INTERSPECIFIC | 1 | 0.7 | 0 | 2 |
| 329 | INTRODUCTORY | 1 | 0.7 | 0 | 9 |
| 330 | INVITRO | 1 | 0.7 | 7 | 54 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 331 | INVIVO | 1 | 0.7 | 11 | 138 |
| 332 | IPSILATERAL | 1 | 0.7 | 0 | 0 |
| 333 | ISOLATION | 1 | 0.7 | 2 | 39 |
| 334 | ISSUES | 1 | 0.7 | 0 | 1 |
| 335 | KARYOPLASTS | 1 | 0.7 | 1 | 9 |
| 336 | LAMBS | 1 | 0.7 | 1 | 10 |
| 337 | LANDRACE-X | 1 | 0.7 | 2 | 33 |
| 338 | LAYING | 1 | 0.7 | 0 | 4 |
| 339 | LEGACY | 1 | 0.7 | 0 | 1 |
| 340 | LENGTHS | 1 | 0.7 | 4 | 117 |
| 341 | LEVELS | 1 | 0.7 | 0 | 2 |
| 342 | LIFESPAN | 1 | 0.7 | 0 | 13 |
| 343 | LIKELY | 1 | 0.7 | 0 | 0 |
| 344 | LIMITATIONS | 1 | 0.7 | 1 | 3 |
| 345 | LIMITED | 1 | 0.7 | 0 | 2 |
| 346 | LINES | 1 | 0.7 | 2 | 39 |
| 347 | LIVES | 1 | 0.7 | 0 | 1 |
| 348 | LONG-TERM | 1 | 0.7 | 0 | 35 |
| 349 | LOSS | 1 | 0.7 | 1 | 104 |
| 350 | LUTEA | 1 | 0.7 | 0 | 22 |
| 351 | MAINTENANCE | 1 | 0.7 | 3 | 34 |
| 352 | MARE | 1 | 0.7 | 1 | 46 |
| 353 | MATERIAL | 1 | 0.7 | 2 | 10 |
| 354 | MATTERS | 1 | 0.7 | 0 | 0 |
| 355 | MATURED | 1 | 0.7 | 0 | 0 |
| 356 | MAY | 1 | 0.7 | 0 | 1 |
| 357 | MEDIA | 1 | 0.7 | 3 | 26 |
| 358 | MEN | 1 | 0.7 | 0 | 34 |
| 359 | MICROSATELLITE | 1 | 0.7 | 3 | 29 |
| 360 | MITOCHONDRIAL | 1 | 0.7 | 0 | 84 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 361 | MODERATELY | 1 | 0.7 | 0 | 1 |
| 362 | MODIFICATION | 1 | 0.7 | 0 | 0 |
| 363 | MODIFY | 1 | 0.7 | 0 | 6 |
| 364 | MORAL | 1 | 0.7 | 0 | 0 |
| 365 | MRNA | 1 | 0.7 | 0 | 2 |
| 366 | MULTIPOTENTIALITY | 1 | 0.7 | 0 | 19 |
| 367 | NEPHROPATHY | 1 | 0.7 | 0 | 0 |
| 368 | NOCODAZOLE | 1 | 0.7 | 0 | 31 |
| 369 | NON-CONSERVATION | 1 | 0.7 | 0 | 8 |
| 370 | NOVEL | 1 | 0.7 | 0 | 2 |
| 371 | NUCLEAR-CYTOPLASMIC | 1 | 0.7 | 8 | 120 |
| 372 | NUCLEUS | 1 | 0.7 | 2 | 10 |
| 373 | OVARIAN | 1 | 0.7 | 0 | 3 |
| 374 | PATHOLOGY | 1 | 0.7 | 1 | 10 |
| 375 | PCR-BASED | 1 | 0.7 | 0 | 12 |
| 376 | PELLET | 1 | 0.7 | 1 | 3 |
| 377 | PERFORMANCE | 1 | 0.7 | 0 | 17 |
| 378 | PERI-OVULATORY | 1 | 0.7 | 0 | 109 |
| 379 | PERIOVULATORY | 1 | 0.7 | 1 | 57 |
| 380 | PERMEATING | 1 | 0.7 | 2 | 20 |
| 381 | PHARMACEUTICALS | 1 | 0.7 | 4 | 77 |
| 382 | PHARMACOGENETICS | 1 | 0.7 | 0 | 0 |
| 383 | PLACENTAE | 1 | 0.7 | 4 | 59 |
| 384 | PLASMA | 1 | 0.7 | 1 | 57 |
| 385 | PLOIDY | 1 | 0.7 | 0 | 6 |
| 386 | POTENTIALS | 1 | 0.7 | 0 | 2 |
| 387 | PREGNANT | 1 | 0.7 | 1 | 46 |
| 388 | PRENATAL | 1 | 0.7 | 1 | 104 |
| 389 | PREPARED | 1 | 0.7 | 1 | 9 |
| 390 | PRESUMPTIVE | 1 | 0.7 | 4 | 63 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 391 | PRETREATMENT | 1 | 0.7 | 0 | 26 |
| 392 | PRION | 1 | 0.7 | 6 | 78 |
| 393 | PROBLEMS | 1 | 0.7 | 0 | 0 |
| 394 | PRODUCED | 1 | 0.7 | 12 | 310 |
| 395 | PROFILE | 1 | 0.7 | 0 | 0 |
| 396 | PROFILES | 1 | 0.7 | 4 | 72 |
| 397 | PROLIFERATIVE | 1 | 0.7 | 0 | 13 |
| 398 | PRONUCLEAR | 1 | 0.7 | 3 | 34 |
| 399 | PROTOCOL | 1 | 0.7 | 2 | 7 |
| 400 | PRP | 1 | 0.7 | 6 | 78 |
| 401 | QUANTIFYING | 1 | 0.7 | 0 | 2 |
| 402 | QUESTIONS | 1 | 0.7 | 0 | 1 |
| 403 | QUIESCENCE | 1 | 0.7 | 1 | 6 |
| 404 | RATES | 1 | 0.7 | 0 | 5 |
| 405 | RECENT | 1 | 0.7 | 1 | 7 |
| 406 | RECIPIENT | 1 | 0.7 | 0 | 0 |
| 407 | RECIPROCAL | 1 | 0.7 | 3 | 45 |
| 408 | REDISTRIBUTION | 1 | 0.7 | 0 | 109 |
| 409 | REGENERATION | 1 | 0.7 | 0 | 0 |
| 410 | REGULATION | 1 | 0.7 | 0 | 0 |
| 411 | REGUMATE | 1 | 0.7 | 2 | 33 |
| 412 | RELATION | 1 | 0.7 | 0 | 22 |
| 413 | RELATIONSHIP | 1 | 0.7 | 0 | 22 |
| 414 | REMAIN | 1 | 0.7 | 0 | 2 |
| 415 | REMARK | 1 | 0.7 | 0 | 9 |
| 416 | REMODELING | 1 | 0.7 | 2 | 10 |
| 417 | REPEATABLE | 1 | 0.7 | 0 | 2 |
| 418 | REPLICATION | 1 | 0.7 | 8 | 120 |
| 419 | REPRESSION | 1 | 0.7 | 0 | 56 |
| 420 | REPRODUCTIVE-BIOLOGY | 1 | 0.7 | 0 | 35 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 421 | REPROGRAMMED | 1 | 0.7 | 0 | 4 |
| 422 | REPROGRAMMING | 1 | 0.7 | 0 | 2 |
| 423 | REVOLUTION | 1 | 0.7 | 0 | 2 |
| 424 | RIGHT | 1 | 0.7 | 0 | 1 |
| 425 | RODENTS | 1 | 0.7 | 0 | 1 |
| 426 | RUMINANTS | 1 | 0.7 | 0 | 34 |
| 427 | S-PHASE | 1 | 0.7 | 4 | 63 |
| 428 | SAFE | 1 | 0.7 | 0 | 8 |
| 429 | SAMPLE | 1 | 0.7 | 0 | 2 |
| 430 | SCIENCE | 1 | 0.7 | 0 | 4 |
| 431 | SECRETED | 1 | 0.7 | 0 | 28 |
| 432 | SELECTED | 1 | 0.7 | 0 | 17 |
| 433 | SELECTION | 1 | 0.7 | 0 | 12 |
| 434 | SEMEN-GLYCEROL | 1 | 0.7 | 1 | 10 |
| 435 | SENSITIVITY | 1 | 0.7 | 0 | 17 |
| 436 | SERA | 1 | 0.7 | 3 | 26 |
| 437 | SERUM | 1 | 0.7 | 1 | 46 |
| 438 | SEVEN | 1 | 0.7 | 0 | 2 |
| 439 | SHOOK | 1 | 0.7 | 0 | 2 |
| 440 | SINGLE | 1 | 0.7 | 0 | 2 |
| 441 | SINGLE-CELL | 1 | 0.7 | 3 | 20 |
| 442 | SIZE | 1 | 0.7 | 0 | 6 |
| 443 | SLOW | 1 | 0.7 | 0 | 4 |
| 444 | SOWS | 1 | 0.7 | 0 | 22 |
| 445 | SPAN | 1 | 0.7 | 0 | 22 |
| 446 | SPECIAL | 1 | 0.7 | 0 | 1 |
| 447 | STEM-CELL | 1 | 0.7 | 2 | 39 |
| 448 | STRATEGIES | 1 | 0.7 | 1 | 21 |
| 449 | SUCCESSFUL | 1 | 0.7 | 2 | 22 |
| 450 | SUGAR | 1 | 0.7 | 1 | 8 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 451 | SUPPLEMENTED | 1 | 0.7 | 3 | 26 |
| 452 | SURGICAL | 1 | 0.7 | 6 | 82 |
| 453 | SYMPOSIUM | 1 | 0.7 | 0 | 0 |
| 454 | TECHNOLOGY | 1 | 0.7 | 0 | 0 |
| 455 | TELOMERASE-IMMORTALIZED | 1 | 0.7 | 0 | 4 |
| 456 | TELOMERE | 1 | 0.7 | 4 | 117 |
| 457 | TEMPERATURE | 1 | 0.7 | 0 | 49 |
| 458 | TOTIPOTENCY | 1 | 0.7 | 0 | 19 |
| 459 | TRAITS | 1 | 0.7 | 0 | 22 |
| 460 | TRANSCUTANEOUS | 1 | 0.7 | 0 | 0 |
| 461 | TRANSFECTED | 1 | 0.7 | 12 | 310 |
| 462 | TRANSFER-DERIVED | 1 | 0.7 | 0 | 84 |
| 463 | TRANSFERASE | 1 | 0.7 | 6 | 78 |
| 464 | TRANSFERRED | 1 | 0.7 | 0 | 5 |
| 465 | TRANSGENES | 1 | 0.7 | 0 | 12 |
| 466 | TRANSGENESIS | 1 | 0.7 | 0 | 0 |
| 467 | TRANSPLANTED | 1 | 0.7 | 0 | 14 |
| 468 | ULTRASONOGRAPHY | 1 | 0.7 | 0 | 0 |
| 469 | UNDERGO | 1 | 0.7 | 0 | 4 |
| 470 | UNIFORMITY | 1 | 0.7 | 1 | 35 |
| 471 | USEFUL | 1 | 0.7 | 0 | 1 |
| 472 | VALUE | 1 | 0.7 | 1 | 7 |
| 473 | VESICLE | 1 | 0.7 | 2 | 10 |
| 474 | VIABILITY | 1 | 0.7 | 0 | 14 |
| 475 | VIVO | 1 | 0.7 | 0 | 0 |
| 476 | WARNING | 1 | 0.7 | 0 | 34 |
| 477 | WHITE-PIGS | 1 | 0.7 | 1 | 35 |
| 478 | WILMUT | 1 | 0.7 | 0 | 0 |
| 479 | WORK | 1 | 0.7 | 0 | 13 |
| 480 | WORLD | 1 | 0.7 | 0 | 2 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 481 | ZYGOTES | 1 | 0.7 | 2 | 50 |